Is a complete DCOY research report available?

No complete published report is available for Decoy Therapeutics Inc. (DCOY) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Decoy Therapeutics Inc. (DCOY)

NASDAQ: DCOY · USD

$5.04

+0.10 (+2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DCOY analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.7M
Net income (ttm)	-13M
EPS (ttm)	-$57.1
Shares out	532K
Volume	9,632
Beta	0.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -13M
EPS (ttm): -$57.1
Market cap: 2.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All DCOY indicators

Market & fundamental data

Available fields

168

Groups with data

Currency

USD

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001615219
Company name	Decoy Therapeutics Inc.
Country	United States
Country code	US
Cusip	79400X602
Employees	11
Employees Change	9%
Employees Change Percent	450
Enterprise value	$-5.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US79400X6022
Last refreshed	2026-07-25
Market cap	$2.7M
Market cap category	Nano-Cap
Price	$5.04
Price currency	USD
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Symbol	DCOY
Website	https://decoytx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-478.53%
FCF yield	-239.93%
P/B ratio	0.68x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-13M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-54.13
Roa5y	-52.59
ROCE	-57.37
ROE	-661.7
Roe5y	-166.6
ROIC	-143.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-96.18%
Cagr3y	-85.27%
Cagr5y	-82.69%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.4M
Cash	$7.8M
Current Assets	$8.4M
Current Liabilities	$4.5M
Debt	$0
Equity	$3.9M
Liabilities	$4.5M
Long Term Assets	$65,623
Long Term Liabilities	$0
Net Cash	$7.8M
Net Cash By Market Cap	$287
Net Cash Growth	363.81%
Net Debt Equity	$-2.02
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$7.29
WACC	7.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.84
Net Working Capital	$-4M
Quick ratio	1.72
Working Capital	$3.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-178.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-96.17%
200-day SMA	12.39
3Y total return	-99.68%
50-day SMA	6.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.98%
All Time High	533,354
All Time High Change	-100%
All Time High Date	2019-07-25
All Time Low	4.32
All Time Low Change	11.81%
All Time Low Date	2026-05-15
ATR	0.88
Beta	0.59
Beta1y	3.27
Beta2y	1.94
Ch YTD	-37.97
High	5.38
High52	415.8
High52 Date	2025-07-29
High52ch	-98.79%
Low	4.8
Low52	4.32
Low52 Date	2026-05-15
Low52ch	16.67%
Ma50ch	-23.41%
Price vs 200-day SMA	-61.01%
RSI	41.09
RSI Monthly	23
RSI Weekly	32.08
Sharpe ratio	-1.19x
Sortino ratio	-1.78
Total Return	-178.55%
Tr YTD	-37.96
Tr1m	-19.5%
Tr1w	-13.9%
Tr3m	-10.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-2.88
Operating Income	$-4.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	528,854%
Float Percent	99.41%
Net Borrowing	-112,230
Shares Insiders	0.59%
Shares Institutions	1.23%
Shares Out	531,968
Shares Qo Q	38.99%
Shares Yo Y	178.55%
Short Float	29.56%
Short Ratio	0.25
Short Shares	29.38

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.9M
Average Volume	684,457.55x
Bv Per Share	7.29
Ch1m	-19.5
Ch1w	-13.9
Ch1y	-96.17
Ch3m	-10.89
Ch3y	-99.68
Ch5y	-99.98
Ch6m	-48.4
Change	2.02%
Change From Open	-1.56
Close	4.94
Days Gap	3.64
Depreciation Amortization	11,969
Dollar Volume	48,545.3
Earnings Date	2026-08-16
Earnings Time	bmo
EBIT	$-2.2M
EBITDA	$-2.2M
EPS	$-57.12
F Score	2
FCF	$-6.5M
FCF EV Yield	128.21x
FCF Per Share	$-12.28
Financing CF	11,792,296
Fiscal Year End	December
Investing CF	764,735
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2026-03-09
Last Split Type	Reverse
Ma150	7.25
Ma150ch	-33.34%
Ma20	6.2
Ma20ch	-22.06%
Net CF	6,022,228
Next Earnings Date	2026-08-16
Open	5.12
Optionable	No
Position In Range	41.38
Post Close	5.04
Postmarket Change Percent	-5.75
Postmarket Price	$4.75
Ppne	35,741
Price Date	2026-07-24
Ptbv Ratio	0.7
Relative Volume	0.01x
Share Based Comp	398,568
Tr6m	-48.4%
Us State	Texas
Volume	9,632

Decoy Therapeutics Inc. (DCOY)

Coverage state: Market snapshot only — no published research

Generate the first DCOY analysis

Price

Financial snapshot

Fair-value bridge

Latest news · DCOY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DCOY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DCOY

Frequently asked questions